COVID-19 Genomics UK Consortium

COG-UK is a pioneer in the use of large-scale, rapid whole-genome sequencing of SARS-CoV-2, the virus causing the COVID-19 pandemic, to understand viral transmission and evolution, and to inform public health responses and vaccine development.

Viruses sequenced

News & Twitter

Latest Updates

Blog

30 Nov 2021

Tracking SARS-CoV-2 evolution and remdesivir treatment in hospital patients

A recent study has used genomic sequencing of the SARS-CoV-2 virus to help understand how the virus evolves in hospital patients and learn more about the antiviral drug remdesivir.

Blog

23 Nov 2021

“An inspirational person who’s touched every life in the country” – in conversation with Dr June Raine

COG-UK caught up with Dr June Raine, Chief Executive of the Medicines and Healthcare Products Regulatory Agency, to learn more about her experiences during the pandemic and as a woman in science.

Blog

3 Nov 2021

COG-UK Together: Marking 18 months of endeavour and achievement

On Thursday 14th October 2021, members from across the COG-UK consortium came together to share their experiences as part of the collective sequencing effort.

Our Partners

UK-wide genomic sequencing

Our purpose is to provide data that influences public health interventions and policy decisions, and through this make a contribution towards reducing the toll of COVID-19 on our population.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative partnership of NHS organisations, Public Health Agencies, academic partners providing sequencing and analysis capacity, lighthouse labs, and the central sequencing hub of the Wellcome Sanger Institute.